We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
116 hedge funds and large institutions have $808M invested in Sana Biotechnology in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 37 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
171% more call options, than puts
Call options by funds: $333K | Put options by funds: $123K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
3.22% more ownership
Funds ownership: 63% → 66.22% (+3.2%)
5% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 37
1% less funds holding
Funds holding: 117 → 116 (-1)
18% less capital invested
Capital invested by funds: $986M → $808M (-$178M)
Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
14
Increased
39
Reduced
37
Closed
12
Calls
$333K
Puts
$123K
Net Calls
+$210K
Net Calls Change
+$215K
Top Buyers
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$6.5M |
| 2 |
Morgan Stanley
New York
|
-$5.47M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$1.46M |
| 4 |
PGP
Prescott General Partners
Boca Raton,
Florida
|
-$1.23M |
| 5 |
Two Sigma Investments
New York
|
-$1.15M |